Group 1: Market Performance - The consumer sector experienced a decline, with the Consumer ETF (159928) dropping by 0.49%, marking its third consecutive day of decline, and a trading volume exceeding 250 million yuan [1] - The Consumer ETF (159928) saw a net subscription of 26 million units during the day, with a net inflow of 107 million yuan yesterday, accumulating over 390 million yuan in the past 20 days [1] - As of December 2, the latest scale of the Consumer ETF (159928) exceeded 21.3 billion yuan, leading its peers significantly [1] Group 2: Policy and Support Measures - Hunan province introduced 11 measures to boost consumption, emphasizing increased financial support for key consumption areas such as trade circulation and life services [3] - Hainan province issued a child-rearing subsidy plan, providing annual subsidies of 3,600 yuan per child for eligible families starting from January 1, 2025 [3] Group 3: Valuation and Investment Outlook - The Consumer ETF (159928) has a TTM price-to-earnings ratio of 19.89, which is at the 4.41% percentile over the past decade, indicating a high valuation attractiveness [5] - Seasonal trends suggest that Q4 often sees shifts in investment styles, with December being a period where low valuation stocks may gain favor [5] Group 4: Future Consumption Trends - According to Jiangyin International, consumer spending is expected to see a slight recovery in 2025, with moderate growth continuing into 2026, driven by structural changes in consumer demand [7] - The consumer confidence index is gradually improving but remains below the threshold, indicating cautious consumer sentiment [7] Group 5: Food and Beverage Sector Insights - Huachuang Securities anticipates that traditional leading companies in the food and beverage sector will improve their market share, while new industry trends are emerging [8] - The food and beverage industry is expected to stabilize after a period of supply-demand imbalance, with a focus on traditional products like beer and dairy [9] - The industry is witnessing a shift towards new demands and business models, with opportunities in functional foods and health products [9]

东鹏饮料（ [Table_StockNameRptType] 605499） 公司点评 H 股发行更近一步，重申三大逻辑 ——东鹏饮料事件点评 | 投资评级：买入（维 [Table_Rank] 持） | | | --- | --- | | 报告日期： | 2025-12-02 | | [Table_BaseData] 收盘价（元） | 266.09 | | 近 12 个月最高/最低 | 338.92/208.80 | | （元） | | | 总股本（百万股） | 520 | | 流通股本（百万股） | 520 | | 流通股比例（%） | 100.00 | | 总市值（亿元） | 1,384 | | 流通市值（亿元） | 1,384 | [公司价格与沪深 Table_Chart] 300 走势比较 -19% 2% 23% 44% 65% 12/24 3/25 6/25 9/25 12/25 东鹏饮料 沪深300 [Table_Author] 分析师：邓欣 执业证书号：S0010524010001 邮箱：dengxin@hazq.com 分析师：韦香怡 执业证书号：S0010525060001 邮箱：weixi ...

2025年11月28日，中国证监会国际合作司发布关于东鹏饮料（集团）股份有限公司(简称东鹏饮料) (605499.SH)境外发行上市备案通知书(国合函[2025]2128号)。根据备案事项，东鹏饮料可发行不超过 6644.60万股普通股并在香港联合交易所上市。 东鹏饮料，于2025年4月3日、2025年10月9日先后两次递交招股书，华泰国际、摩根士丹利、瑞银联席 保荐。 东鹏饮料，成立于1994年，作为中国第一、全球领先的功能饮料企业，收入增速在全球前20大上市软饮 企业中位列第一。公司拥有备受消费者喜爱、拥有国民级影响力的「东鹏」品牌，「累了、困了、喝东 鹏特饮」的品牌主张深入人心。根据弗若斯特沙利文报告，按销量计，东鹏饮料在中国功能饮料市场自 2021年起连续4年排名第一，市场份额从2021年的15.0%增长到2024年的26.3%。 | 纂的[编纂]數目 | : [编纂]股H股(視乎[编纂]行使與否而定) | | --- | --- | | [编纂]數目 | :[编纂]股H股(可于[编纂]) | | [編纂]數目 | : [编纂]股H股(可予[编纂]及視乎[编纂]行使與否而 | | | 定) | | | ...

Group 1: SAIC Motor Corporation - In November, SAIC Motor's total vehicle sales reached 460,800 units, a year-on-year decrease of 3.75% [1] - New energy vehicle sales were 209,400 units, showing a year-on-year increase of 19.75% [1] - Cumulative vehicle sales from January to November reached 4,108,100 units, a year-on-year increase of 16.38% [1] - SAIC's subsidiary plans to establish a private equity fund focused on the smart electric vehicle industry with an initial subscription size of 1.09 billion yuan [1] Group 2: Top Group - Top Group is planning to issue H-shares and list on the Hong Kong Stock Exchange [2] - The company is in discussions with relevant intermediaries regarding the specifics of the H-share listing [2] Group 3: Ningbo Fuda - Ningbo Fuda's subsidiary intends to publicly sell 100% equity of its subsidiary, Hekou Yingzhou Cement Company, with an assessed value of 1.5752 million yuan [4] Group 4: Fuguang Co., Ltd. - Fuguang Co., Ltd. plans to sell a 25% stake in its associate company, Xiaotunpai, for 67.2636 million yuan [5] Group 5: Puluo Pharmaceutical - Puluo Pharmaceutical's subsidiary received a drug registration certificate for Amoxicillin and Clavulanate Potassium Tablets, used for various infections [6][7] Group 6: Fosun Pharma - Fosun Pharma's subsidiary received approval to conduct Phase I clinical trials for a dual-specific antibody injection for treating advanced solid tumors [8] Group 7: Far East Group - Far East Group's subsidiaries won contracts totaling 2.383 billion yuan in November [9] Group 8: Samsung Medical - Samsung Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 124 million yuan [10] Group 9: Changhua Group - Changhua Group received a development notification from a domestic automaker, with an expected total sales amount of approximately 732 million yuan over five years [12] Group 10: Xinbang Intelligent - Xinbang Intelligent's application for issuing shares to acquire Wuxi Yindichip Microelectronics has been accepted by the Shenzhen Stock Exchange [14] Group 11: Jinjing Development - Jinjing Development's subsidiary won a residential and commercial land bid in Tianjin for 474 million yuan [16] Group 12: Guohong Holdings - Guohong Holdings signed an investment framework agreement to develop a strategic emerging industry park in Tanzhou Town [17] Group 13: Hanma Technology - Hanma Technology reported a 149.94% year-on-year increase in truck sales in November, totaling 2,002 units [22] Group 14: Yufeng Group - Yufeng Group decided to terminate its plan to issue A-shares due to the expiration of authorization and market conditions [24] Group 15: Zhenhua Electric - Zhenhua Electric's subsidiary plans to invest up to 201 million yuan in a private equity fund focused on specific industries, including new energy [28] Group 16: Fuao Co., Ltd. - Fuao Co., Ltd. completed the transfer of 40% equity in Fuao Wan'an for 26.222 million yuan [29] Group 17: Baotailong - Baotailong plans to acquire an additional 2.83% stake in its subsidiary, totaling 15 million yuan [31] Group 18: Zhongchao Holdings - Zhongchao Holdings' subsidiaries won projects totaling 1.318 billion yuan [32] Group 19: Annie Co., Ltd. - Annie Co., Ltd. announced a potential change in control, leading to a temporary suspension of its stock [34] Group 20: Ganfeng Lithium - Ganfeng Lithium's subsidiary plans to issue $100 million in exchangeable notes [38]

Core Insights - A total of 21 buy ratings were issued by institutions today, covering 20 stocks, with Guizhou Moutai receiving the highest attention with two buy ratings [1][2] - Among the rated stocks, 11 provided future target prices, with 7 stocks showing an upside potential exceeding 20%, led by Guizhou Moutai with a target price of 2600.00 CNY, indicating a potential increase of 79.56% [1][2] - The average increase for stocks with buy ratings today was 0.82%, outperforming the Shanghai Composite Index, with notable gainers including Hu Guang Co., Sophia, and Shenzhou Digital [1][2] Company Summaries - Guizhou Moutai received a strong buy rating from Huachuang Securities with a target price of 2600.00 CNY, compared to the latest closing price of 1448.00 CNY [2] - Dongpeng Beverage also received a strong buy rating from Huachuang Securities with a target price of 340.00 CNY, latest closing at 269.03 CNY [2] - Shenzhou Digital was rated as "Increase" by Guotai Junan with a target price of 55.97 CNY, latest closing at 41.27 CNY [2] - Hu Guang Co. was rated as "Strong Buy" by Huachuang Securities with a target price of 37.90 CNY, latest closing at 31.30 CNY [2] - Other notable stocks include Jerry Shares, which was rated "Increase" with a target price of 73.20 CNY, latest closing at 62.07 CNY [2] Industry Insights - The basic chemical industry was the most favored, with stocks like Huhua Co. and Chuanheng Co. receiving buy ratings [2] - The computer and automotive industries also attracted attention, with two stocks each receiving buy ratings [2]

Investment Rating - The report maintains an "Outperform the Market" rating for the food and beverage sector [4][5][15]. Core Views - The food and beverage sector is expected to see a recovery in consumer demand as the year-end approaches, with a positive outlook for 2026 [3][10]. - The report highlights a differentiation in the performance of various sub-sectors, with beverages outperforming food and alcoholic beverages [2][10]. - Key investment opportunities are identified in leading companies within the sector, particularly those with strong growth potential and market positioning [3][10][15]. Summary by Relevant Sections 1. Sector Overview - The food and beverage sector has shown a slight increase of 0.03% this week, with A-shares remaining flat and H-shares up by 0.47% [1]. - The top performers in the sector include Hai Xin Food, Jia Long Co., and Yan Tang Dairy, with significant weekly gains [1]. 2. Sub-sector Analysis - **Alcoholic Beverages**: The report indicates that the liquor sector is in a bottoming phase, with premium brands like Moutai and Luzhou Laojiao expected to gain market share [2][10]. - **Beverages**: The beverage sector is experiencing stable demand recovery, with leading companies like Nongfu Spring and Dongpeng Beverage recommended for investment [2][14]. - **Food**: The snack segment is highlighted for its growth potential, particularly in konjac products, with companies like Wei Long and Yan Jin Pu Zi recommended [2][11]. 3. Investment Recommendations - The recommended investment portfolio includes Moutai, Baba Foods, Dongpeng Beverage, Wei Long, and Luzhou Laojiao, reflecting a diverse range of opportunities across the sector [3][15]. - The report emphasizes the importance of focusing on companies with strong fundamentals and growth trajectories, particularly in the context of changing consumer preferences and market dynamics [2][10][15]. 4. Earnings Forecasts - Earnings forecasts for key companies indicate a positive growth trajectory, with Moutai expected to achieve revenues of approximately 183.5 billion yuan by 2027, reflecting a compound annual growth rate [4][15]. - Other companies like Dongpeng Beverage and Baba Foods are also projected to see significant revenue growth, driven by market expansion and product innovation [15][17].

Market Overview - The beverage and dairy sector increased by 1.12% on December 1, with Sunlight Dairy leading the gains [1] - The Shanghai Composite Index closed at 3914.01, up 0.65%, while the Shenzhen Component Index closed at 13146.72, up 1.25% [1] Stock Performance - Sunlight Dairy (001318) closed at 17.57, up 10.02% with a trading volume of 257,000 shares and a transaction value of 447.1 million [1] - Other notable performers included: - Quan Yang Quan (600189) at 7.54, up 4.72% [1] - Huanle Jia (300997) at 24.39, up 3.39% [1] - Dongpeng Beverage (605499) at 269.03, up 2.04% [1] - Yiming Food (605179) at 22.35, up 1.78% [1] Fund Flow Analysis - The beverage and dairy sector experienced a net outflow of 145 million from institutional investors, while retail investors saw a net inflow of 117 million [2] - The main stocks with significant fund flows included: - Yili Group (600887) with a net outflow of 64.44 million from institutional investors [3] - Sunlight Dairy (001318) with a net inflow of 42.02 million from institutional investors [3] - Chengde Lolo (000848) had a net inflow of 4.49 million from retail investors [3]

根据备案书内容，东鹏饮料拟发行不超过6644.60万股境外上市普通股并在香港联合交易所上市。自备 案通知书出具之日起至本次境外发行上市结束前，公司如发生重大事项，应根据境内企业境外发行上市 有关规定，通过中国证监会备案管理信息系统报告。东鹏饮料完成境外发行上市后15个工作日内，应通 过中国证监会备案管理信息系统报告发行上市情况。 据了解，东鹏饮料2025年4月3日向香港联合交易所递交本次发行申请。10月9日，公司向香港联合交易 所更新了发行申请及部分公司信息和财务数据等。 新京报讯（记者王子扬）12月1日，新京报记者了解到，功能饮料东鹏特饮母公司东鹏饮料（605499） （集团）股份有限公司（简称"东鹏饮料"）发行H股获得中国证监会备案。 对于本次上市，东鹏饮料称，旨在进一步提高公司的资本实力和综合竞争力，提升公司国际化品牌形 象，满足公司国际业务发展需要，深入推进公司全球化战略。募集资金用途包括部分资金将用于在海外 重点市场建立包括仓储在内的供应链基础设施，以满足这些地区（例如印度尼西亚、越南和马来西亚等 东南亚国家）的高速增长需求，并最终实现本地化运营。 东鹏饮料日前披露公告显示，公司正在进行申请发行境外 ...

Core Viewpoint - The China Securities Regulatory Commission has confirmed the overseas listing applications for several companies, including Dongpeng Beverage, Saintong Medical, Youlesai, Linqingxuan, Jinxun Co., Muyuan Foods, Basic Semiconductor, Huasheng Technology, Xiantong International, and Wuyi Vision, with Huasheng Technology applying for a listing in Taiwan and the others in Hong Kong [1]. Group 1: Dongpeng Beverage - Dongpeng Beverage plans to issue no more than 66,446,000 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on beverage R&D, production, and sales, particularly in the functional beverage sector, with products including energy drinks, sports drinks, tea, coffee, plant protein drinks, and fruit and vegetable juices [3]. - Financial projections for Dongpeng Beverage show revenues of 8.5 billion, 11.257 billion, 15.83 billion, and 10.732 billion for 2022 to 2025, with corresponding net profits of 1.441 billion, 2.04 billion, 3.326 billion, and 2.375 billion [3]. Group 2: Saintong Medical - Saintong Medical intends to issue no more than 12,298,300 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company specializes in the R&D, production, and sales of special medical purpose formula foods, particularly in the infant medical food sector [5]. - Financial forecasts for Saintong Medical indicate revenues of 491 million, 654 million, and 834 million for 2022 to 2024, with net profits of 83.89 million, 170 million, and 91.14 million [5]. Group 3: Youlesai - Youlesai plans to issue no more than 26,833,500 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a leading integrated circular packaging service provider for the automotive industry, offering solutions and smart logistics systems [8]. - Financial projections for Youlesai show revenues of 648 million, 794 million, and 838 million for 2022 to 2024, with net profits of 3.12 million, 64.15 million, and 50.74 million [8]. Group 4: Linqingxuan - Linqingxuan intends to issue no more than 16,061,400 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a high-end skincare brand focusing on plant-based skincare products, using camellia oil as a core ingredient [10]. - Financial forecasts for Linqingxuan indicate revenues of 691 million, 805 million, and 1.21 billion for 2022 to 2024, with net profits of -5.93 million, 84.52 million, and 187 million [10]. Group 5: Jinxun Co. - Jinxun Co. plans to issue no more than 42,280,400 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is involved in the development, smelting, and processing of non-ferrous metal new energy materials, with core businesses including cathode copper production and cobalt product processing [11]. - Financial projections for Jinxun Co. show revenues of 637 million, 676 million, and 1.77 billion for 2022 to 2024, with net profits of 84 million, 29 million, and 202 million [11]. Group 6: Muyuan Foods - Muyuan Foods intends to issue no more than 546,276,700 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company operates a full industry chain in pig farming, including feed processing, breeding, and meat processing [12]. - Financial forecasts for Muyuan Foods indicate revenues of 124.8 billion, 110.9 billion, and 138 billion for 2022 to 2024, with net profits of 14.933 billion, -4.168 billion, and 18.925 billion [12]. Group 7: Basic Semiconductor - Basic Semiconductor plans to issue no more than 39,357,800 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on the R&D and industrialization of silicon carbide power devices, with products used in photovoltaic storage and industrial control [15]. - Financial projections for Basic Semiconductor show revenues of 117 million, 221 million, and 299 million for 2022 to 2024, with net losses of 242 million, 342 million, and 237 million [15]. Group 8: Huasheng Technology - Huasheng Technology intends to issue no more than 9,100,000 ordinary shares and list on the Taiwan Stock Exchange [1]. - The company specializes in manufacturing electronic connectors and related products, including automotive wiring harnesses and RF antennas [17]. Group 9: Xiantong International - Xiantong International plans to issue no more than 9,259,900 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company is a comprehensive enterprise focusing on pharmaceutical R&D, production, and sales, with a pipeline targeting oncology and neurodegenerative diseases [19]. - Financial forecasts for Xiantong International indicate revenues of 10.23 million and 44.06 million for 2022 to 2024, with net losses of 309 million and 156 million [19]. Group 10: Wuyi Vision - Wuyi Vision intends to issue no more than 77,600,840 overseas ordinary shares and list on the Hong Kong Stock Exchange [1]. - The company focuses on digital twin technology, providing applications for smart cities and industrial simulation [21]. - Financial projections for Wuyi Vision show revenues of 170 million, 256 million, and 287 million for 2022 to 2024, with net losses of 190 million, 87 million, and 82 million [21].

Investment Rating - The report maintains a "Strong Buy" rating for Dongpeng Beverage, with a target price of 340 CNY [2][6]. Core Views - Dongpeng Beverage has received approval for its H-share issuance, which is expected to alleviate market concerns and enhance its competitive position through strategic investments in overseas capacity, supply chain upgrades, and brand building [2][6]. - The company is projected to maintain high-quality growth in the short term, with a focus on scaling operations and improving profitability through digitalization and cost efficiency [6][7]. - The strategic restructuring into five major regions aims to enhance operational flexibility and drive sales growth, positioning Dongpeng as a leader in the functional beverage sector [6][7]. Company Overview - Total shares outstanding: 52,001.30 million - Total market capitalization: 137.11 billion CNY - Asset-liability ratio: 63.24% - Net asset per share: 16.92 CNY - 12-month price range: 336.50 CNY (high) / 209.99 CNY (low) [3][6]. Financial Projections - Revenue forecast for 2024: 15,839 million CNY, with a year-on-year growth of 40.6% - Net profit forecast for 2024: 3,326 million CNY, with a year-on-year growth of 63.1% - Projected earnings per share for 2024: 6.40 CNY [7][8]. Strategic Focus - The company aims to leverage high-demand functional beverages and enhance its market presence through effective distribution and marketing strategies [6][7]. - The focus on digital transformation is expected to yield significant operational efficiencies and contribute positively to profit margins [6][7].